These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7423681)

  • 1. Urodynamic effects of intravenous benzilonium bromide in healthy subjects.
    Nyman CR
    Urol Int; 1980; 35(5):363-8. PubMed ID: 7423681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urodynamic effects of oral benzilonium bromide in healthy subjects.
    Nyman CR
    Urol Int; 1981; 36(1):67-72. PubMed ID: 7257013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urodynamic and clinical evidence of acute inhibitory effects of intravesical nociceptin/orphanin FQ on detrusor overactivity in humans: a pilot study.
    Lazzeri M; Calò G; Spinelli M; Guerrini R; Beneforti P; Sandri S; Zanollo A; Regoli D; Turini D
    J Urol; 2001 Dec; 166(6):2237-40. PubMed ID: 11696742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental study of urodynamic effects of epidural morphine and of naloxone reversal.
    Rawal N; Möllefors K; Axelsson K; Lingårdh G; Widman B
    Anesth Analg; 1983 Jul; 62(7):641-7. PubMed ID: 6859567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors that influence the urodynamic results of botulinum toxin in the treatment of neurogenic hyperactivity.
    Gutiérrez-Martín P; Vírseda-Chamorro M; Salinas Casado J; Gómez-Rodríguez A; Esteban-Fuertes M
    Actas Urol Esp; 2015 May; 39(4):217-21. PubMed ID: 25582926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2010 Mar; 183(3):1092-7. PubMed ID: 20092847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urodynamic effects of once daily tadalafil in men with lower urinary tract symptoms secondary to clinical benign prostatic hyperplasia: a randomized, placebo controlled 12-week clinical trial.
    Dmochowski R; Roehrborn C; Klise S; Xu L; Kaminetsky J; Kraus S
    J Urol; 2013 Jan; 189(1 Suppl):S135-40. PubMed ID: 23234619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vardenafil improves urodynamic parameters in men with spinal cord injury: results from a single dose, pilot study.
    Gacci M; Del Popolo G; Macchiarella A; Celso M; Vittori G; Lapini A; Serni S; Sandner P; Maggi M; Carini M
    J Urol; 2007 Nov; 178(5):2040-3; discussion 2044. PubMed ID: 17869296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic effect of thiphenamil HCl on lower urinary tract function of healthy asymptomatic volunteers.
    Constantinou CE
    Urol Int; 1992; 48(3):293-8. PubMed ID: 1589919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of bethanechol and cisapride on urodynamic parameters in patients undergoing radical hysterectomy for cervical cancer. A randomized, double-blind, placebo-controlled study.
    Madeiro AP; Rufino AC; Sartori MG; Baracat EC; Lima GR; Girão MJ
    Int Urogynecol J Pelvic Floor Dysfunct; 2006 May; 17(3):248-52. PubMed ID: 15959612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is a representative voiding pattern in children with lower urinary tract symptoms? Lack of consistent findings in ambulatory and conventional urodynamic tests.
    Lu YT; Jakobsen LK; Djurhuus JC; Bjerrum SN; Wen JG; Olsen LH
    J Pediatr Urol; 2016 Jun; 12(3):154.e1-7. PubMed ID: 26944608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical resiniferatoxin versus botulinum-A toxin injections for neurogenic detrusor overactivity: a prospective randomized study.
    Giannantoni A; Di Stasi SM; Stephen RL; Bini V; Costantini E; Porena M
    J Urol; 2004 Jul; 172(1):240-3. PubMed ID: 15201783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity.
    Reitz A; Denys P; Fermanian C; Schurch B; Comperat E; Chartier-Kastler E
    Eur Urol; 2007 Dec; 52(6):1729-35. PubMed ID: 17884281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intravesical Resiniferatoxin (RTX) on lower urinary tract symptoms, urodynamic parameters, and quality of life of patients with urodynamic increased bladder sensation.
    Apostolidis A; Gonzales GE; Fowler CJ
    Eur Urol; 2006 Dec; 50(6):1299-305. PubMed ID: 16697519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intravesical botulinum neurotoxin-A injection on detrusor hyperreflexia in spinal cord injured patients.
    Ge XT; Li YF; Wang Q; Zhao JN
    Drug Res (Stuttg); 2015 Jun; 65(6):327-31. PubMed ID: 25350080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed urodynamic pressure-flow nomogram to diagnose female bladder outlet obstruction.
    Di Grazia E; Troyo Sanromán R; Aceves JG
    Arch Ital Urol Androl; 2004 Jun; 76(2):59-65. PubMed ID: 15270415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin A detrusor injections in patients with neurogenic detrusor overactivity significantly decrease the incidence of symptomatic urinary tract infections.
    Gamé X; Castel-Lacanal E; Bentaleb Y; Thiry-Escudié I; De Boissezon X; Malavaud B; Marque P; Rischmann P
    Eur Urol; 2008 Mar; 53(3):613-8. PubMed ID: 17804150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of dopamine receptors in vesicourethral function. A urodynamic study with dopamine receptor antagonist metoclopramide.
    Vaidyanathan S; Rao MS; Bapna BC; Chary KS; Swamy RP
    Ann Clin Res; 1980 Feb; 12(1):1-4. PubMed ID: 7377750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the gonadotropin-releasing hormone antagonist ganirelix on normal micturition and prostaglandin E(2)-induced detrusor overactivity in conscious female rats.
    Russo A; Castiglione F; Salonia A; Benigni F; Rigatti P; Montorsi F; Andersson KE; Hedlund P
    Eur Urol; 2011 May; 59(5):868-74. PubMed ID: 21196074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urodynamics and safety of the β₃-adrenoceptor agonist mirabegron in males with lower urinary tract symptoms and bladder outlet obstruction.
    Nitti VW; Rosenberg S; Mitcheson DH; He W; Fakhoury A; Martin NE
    J Urol; 2013 Oct; 190(4):1320-7. PubMed ID: 23727415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.